If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMADE.L Regulatory News (MADE)

  • There is currently no data for MADE

Form 8.3 - MADE.COM GROUP PLC

18 Oct 2022 12:38

RNS Number : 2915D
Barclays PLC
18 October 2022
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

MADE.COM GROUP PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

17 Oct 2022

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

0.01p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

4,773,208

1.21%

1,288,865

0.33%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

2,269,346

0.57%

4,999,660

1.26%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

7,042,554

1.78%

6,288,525

1.59%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

0.01p ordinary

Purchase

80,087

0.0847 GBP

0.01p ordinary

Purchase

289,829

0.0831 GBP

0.01p ordinary

Sale

1,000

0.0783 GBP

0.01p ordinary

Sale

28,000

0.0800 GBP

0.01p ordinary

Sale

120,087

0.0865 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

0.01p ordinary

SWAP

Long

1,000

0.0783 GBP

0.01p ordinary

SWAP

Long

28,000

0.0800 GBP

0.01p ordinary

SWAP

Long

40,000

0.0899 GBP

0.01p ordinary

SWAP

Short

289,829

0.0831 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

18 Oct 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETUWOARUBURAAA
Date   Source Headline
21st Jun 202212:41 pmRNSBlock Listing Application
16th May 20227:01 amRNSDirectorate Change
16th May 20227:00 amRNSTrading Update
9th May 20227:00 amRNSAcquisition
5th May 20224:23 pmRNSResult of AGM
5th May 20228:30 amRNSDirectorate Change
11th Apr 202211:59 amRNSHolding(s) in Company
6th Apr 202212:43 pmRNSDirector/PDMR Shareholding
1st Apr 202212:25 pmRNSNotice of AGM
25th Mar 20227:00 amRNSDirectorate Change
17th Mar 202211:26 amRNSAnnual Financial Report
8th Mar 20227:00 amRNSPreliminary Results
28th Feb 202211:26 amRNSTotal Voting Rights
21st Feb 20227:00 amRNSDirectorate Change
31st Jan 202210:17 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSTrading Statement
31st Dec 20219:38 amRNSTotal Voting Rights
21st Dec 202110:31 amRNSBlock listing Interim Review
15th Dec 20213:31 pmRNSCompletion of Capital Reduction
9th Dec 20217:00 amRNSTrading Update
30th Nov 202111:01 amRNSTotal Voting Rights
29th Oct 202110:08 amRNSTotal Voting Rights
30th Sep 202110:07 amRNSTotal Voting Rights
14th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
31st Aug 202110:42 amRNSTotal Voting Rights
3rd Aug 20215:01 pmRNSHolding(s) in Company
30th Jul 202111:21 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSNotice of Half Year Results
30th Jul 20217:00 amRNSAppointment of Joint Corporate Brokers
23rd Jul 20212:46 pmRNSHolding(s) in Company
23rd Jul 20211:47 pmRNSHolding(s) in Company
16th Jul 20217:00 amRNSStabilisation Notice
16th Jul 20217:00 amRNSExercise of Over-allotment Option
14th Jul 20217:00 amRNSStabilisation Notice
13th Jul 20214:17 pmRNSDirector/PDMR Shareholding
7th Jul 20217:00 amRNSStabilisation Notice
1st Jul 202112:10 pmRNSHolding(s) in Company
1st Jul 202112:08 pmRNSHolding(s) in Company
30th Jun 202112:10 pmRNSTotal Voting Rights
30th Jun 20217:00 amRNSStabilisation Notice
24th Jun 202110:58 amRNSHolding(s) in Company
24th Jun 202110:47 amRNSDirector/PDMR Shareholding - Correction
23rd Jun 20212:35 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSStabilisation Notice
21st Jun 202110:21 amRNSDirector/PDMR Shareholding
21st Jun 202110:15 amRNSHolding(s) in Company
21st Jun 20218:00 amRNSAdmission to Trading
17th Jun 202111:03 amRNSBlock Listing Application
16th Jun 20211:26 pmRNSApproval and Publication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.